Long-term Safety and Efficacy of Adjunctive Brivaracetam in Chinese Patients With Uncontrolled Focal Epilepsy
Clinical trial NCT07563634 · COMPLETED
Trial details
- NCT number
- NCT07563634
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-07
- Primary completion
- 2024-05-21
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.